Medication info
Crovatin Tablets 5mg (Rosuvastatin Calcium)

Crovatin Tablets 5mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›5.2mg / 1 tablet
Manufacturer / importer
Genufarma Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
28 tablets (14 tablets/Alu-Alu pack x 2), 30 tablets/bottle
Approval status
Active

MFDS item code 201507399 · Approved 2015.10.28 · Insurance code 698003030

Summary

Main use
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. The dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is required. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams per day. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, whereas an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Ethnicity: Because systemic exposure to this medicine is increased in Asian patients, the recommended starting dose is 5 milligrams. The 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 milligrams. In some of these patients, administration of the 40-milligram dose is contraindicated.
Children's dosage
Age 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.

Ingredients

Manufacturer
Genufarma Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • primary dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL-cholesterol levels
  • smoking
  • family history of early coronary heart disease
View approved original text

This medication is mainly used as an adjunct therapy when dietary measures and exercise alone are insufficient to control primary hypercholesterolemia and mixed hyperlipidemia patients. It is also used in conjunction with other lipid-lowering therapies for patients with homozygous familial hypercholesterolemia and helps lower the total cholesterol and LDL-cholesterol levels in patients with hypercholesterolemia to slow the progression of atherosclerosis. It is additionally used as an adjunct to diet in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia to reduce cholesterol levels. Patients with primary dysbetalipoproteinemia can also benefit from the dietary adjunct of this medication. Finally, it helps reduce the risk of stroke, myocardial infarction, and vascular reintervention in older adults at high risk for cardiovascular diseases. This medication is used for the treatment and prevention of various conditions associated with hyperlipidemia.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. The dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is required. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams per day. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, whereas an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Ethnicity: Because systemic exposure to this medicine is increased in Asian patients, the recommended starting dose is 5 milligrams. The 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 milligrams. In some of these patients, administration of the 40-milligram dose is contraindicated.

Children's dosage

Age 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. For example, patients with allergies to any component of this drug, those with severely impaired liver function, patients with muscle disorders and severe kidney diseases should not be administered this medication. Moreover, women who are pregnant or breastfeeding and those of childbearing potential who do not use adequate contraception should consult a physician before taking this medication. This medication can affect liver function, hence patients with a history of liver disease or those who consume alcohol heavily should undergo regular liver function tests. If symptoms such as muscle pain or weakness occur, inform a physician immediately and discontinue treatment if necessary. This medication may increase blood concentrations when taken with certain drugs, raising the risk of muscle diseases, thus patients taking other medications should inform their physician or pharmacist. Women of childbearing potential should use effective contraceptive methods while on this medication, and discontinue its use immediately upon confirming pregnancy. Breastfeeding mothers should also avoid taking this medication. In the case of overdose, there is no specific antidote, so treatment must be symptomatic, with monitoring of liver function and muscle enzyme levels. During the use of this medication, dizziness or headaches may occur, so caution is advised when driving or operating machinery. Lastly, this medication contains lactose and may not be suitable for patients with lactose intolerance. Be sure to discuss any health conditions and other medications being taken with medical personnel before using this medication.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, increased CK, increased AST, joint pain, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute kidney failure, oliguria, increased serum creatinine

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture entry, at a cool room temperature ideally between 1 and 30 degrees Celsius. This helps maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

28 tablets (14 tablets/Alu-Alu pack x 2), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.